Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

Withdrawal of the Marketing Authorisation Application of COVID-19 Vaccine Candidate Skycovion

SK Chemicals GmbH withdrew its application for a marketing authorisation of the recombinant protein-based vaccine candidate Skycovion for the prevention of COVID-19 on 1 September 2023. The marketing authorisation application had been under review by the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) since August 2022. The CHMP informed that the company had not provided enough data to support the application. The company stated that its withdrawal was based on commercial reasons.